Shanghai Yizhong Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was CNY 4.08 million. Net loss was CNY 4 million compared to CNY 21.85 million a year ago.

Basic loss per share from continuing operations was CNY 0.0368 compared to CNY 0.2059 a year ago.